iBio reports FY2026 net loss and revenue with $88.0M cash
iBio reported FY2026 net loss of $33.0M and revenue of $0.1M. Cash and investments totaled $88.0M.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.